Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry

Aim: The aim of the study is to up date informations on the clinical characteristics and outcome of patients with upper-extremity deep vein thrombosis (DVT) from the Informatised Registry on Venous Thromboembolism (RIETE). Methods: RIETE is an ongoing registry of consecutive patients with symptomati...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2006
Автори: Monreal, M., Munoz, F.J., Rosa, V., Romero, C., Roman, P., Di Micco, P., Prandoni, P.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2006
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/137569
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry / M. Monreal, F.J. Munoz, V. Rosa, C. Romero, P. Roman, P. Di Micco, P. Prandoni // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 245-247. — Бібліогр.: 14 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-137569
record_format dspace
spelling irk-123456789-1375692018-06-18T03:06:35Z Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry Monreal, M. Munoz, F.J. Rosa, V. Romero, C. Roman, P. Di Micco, P. Prandoni, P. Short communications Aim: The aim of the study is to up date informations on the clinical characteristics and outcome of patients with upper-extremity deep vein thrombosis (DVT) from the Informatised Registry on Venous Thromboembolism (RIETE). Methods: RIETE is an ongoing registry of consecutive patients with symptomatic, objectively confirmed, acute venous thromboembolism. In this analysis the clinical characteristics and 3-month outcome of all cancer patients with upper-extremity DVT were evaluated. Results: Up to February 2006, a total of 14,391 patients with symptomatic, objectively confirmed acute venous thromboembolism had been enrolled in RIETE. Of the 2,945 patients with active cancer 196 (6.7%) had arm DVT: 104 had catheter-associated DVT. Most cancer patients with arm DVT were males, younger than 65, and had a low incidence of additional risk factors or underlying diseases. Twenty of them (10%) had symptomatic pulmonary embolism (PE). Most patients were treated with low-molecular-weigh heparin, both initially (94%) and after discharge (75%). During the 3-month follow-up period 12 patients (6.1%) developed VTE recurrences (PE 6, DVT 6), 8 (4.1%) had major bleeding (fatal in 3), 43 (22%) died. Conclusions: Our data from the RIETE registry show that upper limb DVT is a serious complication in patients with cancer, with a high incidence of recurrences and bleeding complications. Цель: обновить базу данных по клиническим характеристикам и течению заболевания у больных с тромбозом глубоких вен верхних конечностей (ТГВ) с использованием системы регистра венозного тромбоэмболизма (СРВТ). Методы: СРВТ является непрерывной системой регистрации больных с симптомами объективно подтвержденной острой венозной тромбоэмболии. Проанализированы клинические характеристики и течение болезни на протяжении месяцев у больных онкологического профиля с ТГВ. Результаты: в период декабря 2006 г. были обследованы 14 391 больных с симптоматической объективно подтвержденной острой венозной тромбоэмболией при помощи системы СРВТ. Из 2945 больных с прогрессирую­щим течением заболевания у196 (6,7%) человек выявили ТГВ верхних конечностей: у 104 — ассоциированный с катетером ТГВ. Большинство больных с ТГВ верхних конечностей — лица мужского пола в возрасте моложе 65 лет и с низкой частотой дополнительных факторов риска или первичного заболевания. У 20 из них (10%) отмечали симптомы эмболии легочной артерии (ЭЛА). Больные получали низкомолекулярный гепарин и в начале исследования (94%), и по его окончании (75%). В течение последующих трех месяцев у12 больных (6,1%) развился рецидив венозной тромбоэмболии (ВТЭ) (ЭЛА – у 6 больных, ТГВ – у 6 больных), у 8 (4,1%) отмечали кровотечение (3 случая с летальным исходом), 43 (22%) пациента умерли. Выводы: данные СРВТ системы показали, что ТГВ верхних конечностей является серьезным осложнением у больных, онкологического профиля, сочетающимся с высокой степенью развития рецидива и осложнений, сопровождающихся кровотечениями. 2006 Article Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry / M. Monreal, F.J. Munoz, V. Rosa, C. Romero, P. Roman, P. Di Micco, P. Prandoni // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 245-247. — Бібліогр.: 14 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/137569 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Short communications
Short communications
spellingShingle Short communications
Short communications
Monreal, M.
Munoz, F.J.
Rosa, V.
Romero, C.
Roman, P.
Di Micco, P.
Prandoni, P.
Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry
Experimental Oncology
description Aim: The aim of the study is to up date informations on the clinical characteristics and outcome of patients with upper-extremity deep vein thrombosis (DVT) from the Informatised Registry on Venous Thromboembolism (RIETE). Methods: RIETE is an ongoing registry of consecutive patients with symptomatic, objectively confirmed, acute venous thromboembolism. In this analysis the clinical characteristics and 3-month outcome of all cancer patients with upper-extremity DVT were evaluated. Results: Up to February 2006, a total of 14,391 patients with symptomatic, objectively confirmed acute venous thromboembolism had been enrolled in RIETE. Of the 2,945 patients with active cancer 196 (6.7%) had arm DVT: 104 had catheter-associated DVT. Most cancer patients with arm DVT were males, younger than 65, and had a low incidence of additional risk factors or underlying diseases. Twenty of them (10%) had symptomatic pulmonary embolism (PE). Most patients were treated with low-molecular-weigh heparin, both initially (94%) and after discharge (75%). During the 3-month follow-up period 12 patients (6.1%) developed VTE recurrences (PE 6, DVT 6), 8 (4.1%) had major bleeding (fatal in 3), 43 (22%) died. Conclusions: Our data from the RIETE registry show that upper limb DVT is a serious complication in patients with cancer, with a high incidence of recurrences and bleeding complications.
format Article
author Monreal, M.
Munoz, F.J.
Rosa, V.
Romero, C.
Roman, P.
Di Micco, P.
Prandoni, P.
author_facet Monreal, M.
Munoz, F.J.
Rosa, V.
Romero, C.
Roman, P.
Di Micco, P.
Prandoni, P.
author_sort Monreal, M.
title Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry
title_short Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry
title_full Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry
title_fullStr Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry
title_full_unstemmed Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry
title_sort upper extremity dvt in oncological patients: analysis of risk factors. data from the riete registry
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2006
topic_facet Short communications
url http://dspace.nbuv.gov.ua/handle/123456789/137569
citation_txt Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry / M. Monreal, F.J. Munoz, V. Rosa, C. Romero, P. Roman, P. Di Micco, P. Prandoni // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 245-247. — Бібліогр.: 14 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT monrealm upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry
AT munozfj upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry
AT rosav upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry
AT romeroc upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry
AT romanp upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry
AT dimiccop upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry
AT prandonip upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry
first_indexed 2023-10-18T21:14:46Z
last_indexed 2023-10-18T21:14:46Z
_version_ 1796152310711189504